Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease

Pediatric Dermatology

Volumn 30, Issue 1, 2013, Pages 148-150

  Borroni, Riccardo G ^a   Poddighe, Dimitri ^a   Zecca, Marco ^a   Brazzelli, Valeria ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; METHOTREXATE; PREDNISONE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; CRYOTHERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; HUMAN; LEUKEMIA REMISSION; LIVER TOXICITY; MALE; PATIENT REFERRAL; POROKERATOSIS; PRIORITY JOURNAL; PUVA; SKIN GRAFT; TREATMENT DURATION; TREATMENT RESPONSE;

ACITRETIN; ADOLESCENT; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, ACUTE; MALE; POROKERATOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84872316007     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01610.x     Document Type: Article

References (5)

1. Maubec E, Duvillard P, Margulis A, et al., Common skin cancers in porokeratosis. Br J Dermatol 2005; 152: 1360-1398.
2. Leisenring W, Friedman DL, Flowers ME, et al., Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 2006; 24: 1119-1126.
3. Cha SH, Park HJ, Lee JY, et al., Atypical porokeratosis developing following bone marrow transplantation in a patient with myelodisplastic syndrome. Ann Dermatol 2010; 22: 206-208.
4. Hong JB, Hsiao CH, Chu CY,. Systematized linear porokeratosis: a rare variant of diffuse porokeratosis with good response to systemic acitretin. J Am Acad Dermatol 2009; 60: 713-715.
5. Marquez C, Bair SM, Smithberger E, et al., Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. J Drugs Dermatol 2010; 9: 753-758.